Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seagen Inc
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Seagen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Li Auto Powers Up, but Another Stock Is Really Stepping on the Gas
February 27, 2023
The stock market looked poised to climb on Monday morning.
Via
The Motley Fool
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
February 27, 2023
Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 27, 2023
We're starting off Monday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on!
Via
InvestorPlace
Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk
February 27, 2023
US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could...
Via
Benzinga
JMP Securities Maintains Market Outperform Rating for Seagen: Here's What You Need To Know
February 17, 2023
Via
Benzinga
Why Seagen Stock Is Soaring Today
February 16, 2023
Investors and analysts liked what they heard in the company's Q4 update.
Via
The Motley Fool
Seagen, Occidental Petroleum And 3 Stocks To Watch Heading Into Monday
February 27, 2023
With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
February 26, 2023
Via
Benzinga
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 16, 2023
Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.
Via
Benzinga
Seagen (SGEN) Q4 2022 Earnings Call Transcript
February 15, 2023
SGEN earnings call for the period ending December 31, 2022.
Via
The Motley Fool
8 Analysts Have This to Say About Seagen
February 13, 2023
Via
Benzinga
Analyst Ratings for Seagen
January 20, 2023
Via
Benzinga
Analysts Are Bullish On Seagen's Catalyst-Rich Pipeline, Finding No Problem With No M&A
February 16, 2023
Via
Benzinga
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
February 16, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Seattle Genetics' 'Refreshing' Enthusiasm Drives Stock Surge; Alkermes Briefly Breaks Out
February 16, 2023
Seattle Genetics' guidance deliberately excludes a looming opportunity for Padcev.
Via
Investor's Business Daily
Pagaya Technologies To Rally Around Over 120%? Here Are 10 Other Analyst Forecasts For Thursday
February 16, 2023
Keybanc boosted the price target for Twilio Inc. (NYSE: TWLO) from $77 to $89. Keybanc analyst Thomas Blakey maintained an Overweight rating on the stock. Twilio shares gained 6.4% to close at $66.05...
Via
Benzinga
Expert Ratings for Seagen
November 21, 2022
Via
Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
February 14, 2023
These stocks may soon start turning heads with their revenue growth.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
February 06, 2023
Via
Benzinga
RH To Rally Over 15%? Here Are 10 Other Analyst Forecasts For Monday
February 06, 2023
Citigroup boosted the price target for RH (NYSE: RH) from $305 to $380. Citigroup analyst Steven Zaccone maintained a Buy rating. Hershey shares fell 4% to $330.00 in pre-market trading.
Via
Benzinga
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...
Via
Benzinga
Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday
January 25, 2023
Keybanc raised the price target for Reliance Steel & Aluminum Co. (NYSE: RS) from $225 to $235. Keybanc analyst Philip Gibbs maintained an Overweight rating. Reliance Steel shares fell 0.2% to close at...
Via
Benzinga
Seagen's Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer
January 20, 2023
Via
Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Via
Benzinga
Have A Look At William Blair's Top Biotech Picks For 2023
December 25, 2022
William Blair & Company's report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period.
Via
Benzinga
Why Seagen Stock Is Trading Higher During Monday's Session
December 12, 2022
Seagen Inc (NASDAQ: SGEN) shares are trading higher by 4.79% to $129.94 by after the company announced results from the Phase 2 clinical trial of ADCETRIS with novel immunotherapy combination in...
Via
Benzinga
2 Growth Stocks to Buy if the Bear Market Continues in 2023
December 01, 2022
These stocks aren't bargain buys just yet, but they could be soon.
Via
The Motley Fool
Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout
November 21, 2022
Seagen who? Merck is putting its cash to work buying a smaller biotech company.
Via
Investor's Business Daily
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
November 21, 2022
Via
Benzinga
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
November 10, 2022
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.